• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

0.05%丙酸氯倍他索乳膏和软膏,但相应的0.1%曲安奈德制剂不会增加皮肤表面粗糙度:不良表皮和真皮效应可能存在分离。

0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.

作者信息

Kerscher M J, Korting H C, Mehringer L, Mätzig R

机构信息

Dermatologische Klinik, Ludwig-Maximilians-Universität, München, Deutschland.

出版信息

Skin Pharmacol. 1996;9(2):120-3. doi: 10.1159/000211407.

DOI:10.1159/000211407
PMID:8722606
Abstract

Repeated open application of clobetasol 17-propionate cream and ointment to normal skin over a period of 6 weeks induced an increase in skin surface roughness as assessed by profilometry (p < 0.05), while 6 weeks' application of triamcinolone acetonide cream and ointment did not. The increase in skin roughness with clobetasol 17-propionate cream turned out to be greater than with ointment containing identical amounts of clobetasol 17-propionate (p < 0.05). A clear-cut correlation between increase of skin surface roughness and skin thickness as assessed by high-frequency ultrasound could be demonstrated only with clobetasol 17-propionate cream and ointment.

摘要

在6周的时间里,对正常皮肤反复外用丙酸氯倍他索乳膏和软膏,通过轮廓仪评估发现皮肤表面粗糙度增加(p < 0.05),而外用曲安奈德乳膏和软膏6周则未出现这种情况。结果表明,丙酸氯倍他索乳膏导致的皮肤粗糙度增加大于含等量丙酸氯倍他索的软膏(p < 0.05)。仅在丙酸氯倍他索乳膏和软膏中,通过高频超声评估发现皮肤表面粗糙度增加与皮肤厚度之间存在明确的相关性。

相似文献

1
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.0.05%丙酸氯倍他索乳膏和软膏,但相应的0.1%曲安奈德制剂不会增加皮肤表面粗糙度:不良表皮和真皮效应可能存在分离。
Skin Pharmacol. 1996;9(2):120-3. doi: 10.1159/000211407.
2
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis.根据超声分析比较中效和强效外用糖皮质激素乳膏和软膏的致萎缩潜力。
Skin Pharmacol. 1992;5(2):77-80. doi: 10.1159/000211022.
3
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.0.25%的丙缩羟强的松龙乳膏及其相应的赋形剂比0.1%的倍他米松-17-戊酸酯乳膏和0.05%的丙酸氯倍他索乳膏引起的皮肤萎缩更少。
Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477.
4
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.丙酸氯倍他索序贯卡泊三醇在银屑病局部治疗中优于单用卡泊三醇。
J Eur Acad Dermatol Venereol. 1998 Jul;11(1):19-24.
5
Pharmaceutical availability of clobetasol-17-propionate from cream and ointment.丙酸氯倍他索乳膏和软膏的药物可及性。
Acta Pol Pharm. 2001 Nov-Dec;58(6):435-8.
6
Epidermal thinning: evaluation of commercial corticosteroids.表皮变薄:市售皮质类固醇的评估
Arch Dermatol Res. 1980;267(1):7-24. doi: 10.1007/BF00416917.
7
A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.0.05%丙酸氯倍他索软膏与优化后的0.05%二丙酸倍他米松软膏治疗银屑病的比较。
Cutis. 1986 Mar;37(3):213-4, 216, 218-20.
8
Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.外用丙酸氯倍他索治疗银屑病:新型制剂综述
Am J Clin Dermatol. 2009;10(6):397-406. doi: 10.2165/11311020-000000000-00000.
9
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness.
Skin Pharmacol. 1994;7(4):231-6. doi: 10.1159/000211299.
10
Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB.
J Dermatol. 2005 Nov;32(11):868-74. doi: 10.1111/j.1346-8138.2005.tb00863.x.